Income Taxes (Tables)

9 Months Ended

Sep. 30, 2020

Income Tax Disclosure [Abstract]

Restatement to Prior Year Income

The impact to our previously issued condensed consolidated financial statements was as follows:

	As of September 30, 2019
Condensed Consolidated Balance Sheet	Previously Reported		Revision		As Revised
Non-current deferred income tax assets, net (a)	$	38	$	(19)	$	19
Total assets	3,328		(19)		3,309
Deferred income taxes	11		34		45
Total liabilities	1,989		34		2,023
Accumulated deficit	(939)		(53)		(992)
Total shareholders’ equity	1,329		(53)		1,276
Total liabilities, redeemable non-controlling interests, and shareholders’ equity	$	3,328	$	(19)	$	3,309
(a) Included in Investments and other.
	Three Months Ended September 30, 2019
Condensed Consolidated Statement of Operations	Previously Reported		Revision		As Revised
Income tax benefit (expense)	$	60	$	(53)	$	7
Net income (loss)	(909)		(53)		(962)
Net income (loss) attributable to Covetrus	$	(906)	$	(53)	$	(959)
Earnings (loss) per share attributable to Covetrus:
Basic	$	(8.09)	$	(0.47)	$	(8.56)
Diluted	$	(8.09)	$	(0.47)	$	(8.56)
	Nine Months Ended September 30, 2019
Condensed Consolidated Statement of Operations	Previously Reported		Revision		As Revised
Income tax benefit (expense)	$	60	$	(53)	$	7
Net income (loss)	(932)		(53)		(985)
Net income (loss) attributable to Covetrus	$	(929)	$	(53)	$	(982)
Earnings (loss) per share attributable to Covetrus:
Basic	$	(8.76)	$	(0.50)	$	(9.26)
Diluted	$	(8.76)	$	(0.50)	$	(9.26)